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Trafficking, localization and 
degradation of the Na+,HCO3−  
co-transporter NBCn1 in kidney and 
breast epithelial cells
Christina Wilkens Olesen, Jens Vogensen, Ida Axholm, Marc Severin, Julie Schnipper,  
Isabella Skandorff Pedersen, Jakob Hjorth von Stemann, Jacob Morville Schrøder,  
Dan Ploug Christensen & Stine Falsig Pedersen  
The Na+;HCO3− co-transporter NBCn1 (SLC4A7) is a major regulator of intracellular pH yet its 
trafficking and turnover are essentially unstudied. Here, we used MDCK-II and MCF-7 cells to 
investigate these processes in epithelial cells. GFP-NBCn1 membrane localization was abolished by 
truncation of the full NBCn1 C-terminal tail (C-tail) yet did not require the C-terminal PDZ-binding 
motif (ETSL). Glutathione-S-Transferase-pulldown of the C-tail followed by mass spectrometry analysis 
revealed putative interactions with multiple sorting-, degradation- and retention factors, including 
the scaffolding protein RACK1. Pulldown of FLAG-tagged deletion constructs mapped the RACK1 
interaction to the proximal NBCn1 C-tail. Proximity Ligation Assay and co-immunoprecipitation 
confirmed that native NBCn1 interacts with RACK1 in a cellular context. Consistent with a functional 
role of this complex, RACK1 knockdown reduced NBCn1 membrane localization without affecting 
total NBCn1 expression. Notably, only non-confluent cells exhibited detectable NBCn1-RACK1 plasma 
membrane co-localization, suggesting that RACK1 regulates the trafficking of NBCn1 to the membrane. 
Whereas total NBCn1 degradation was slow, with a half-life of more than 24 h, one-third of surface 
NBCn1 was constitutively endocytosed from the basolateral membrane within 60 min. This suggests 
that a fraction of NBCn1 exhibits recycling between the basolateral membrane and intracellular 
compartment(s). Our findings have important implications for understanding NBCn1 regulation as well 
as its dysregulation in disease.
The electroneutral Na+;HCO3− co-transporter NBCn1 (SLC4A7) is a member of the SLC4 family of bicarbonate 
transport proteins and is a major mediator of net cellular acid extrusion in most tissues studied1,2. NBCn1 is 
widely expressed in many human organs and plays essential roles for their normal physiological function. In 
turn, NBCn1 dysfunction has been linked to cardiovascular diseases and more recently to breast cancer1,3–5. 
Thus, NBCn1 expression is increased in at least some human breast cancer tissues compared to normal tissue6,7, 
NBCn1 knockout mice exhibit reduced breast tumor development after chemical carcinogenesis8, and stable 
knockdown of NBCn1 reduces xenograft growth of human breast cancer cells in immunosuppressed mice7. We 
have demonstrated that NBCn1 transcription in human breast cancer cells is controlled by oncogenic human 
epidermal growth factor receptor 2 (p95HER2) signaling via the transcription factor Krüppel like factor 4 (KLF4), 
downstream from phosphatidylinositol-3 kinase (PI3K)/Akt and Ras/Raf/MEK/ERK activation9. Furthermore, 
expression of the p95HER2 receptor also increased NBCn1 mRNA stability10.
Bioinformatic analysis and comparison with the recent crystal structure of the Cl−/HCO3− exchanger 1 (AE1)11 
suggests a membrane topology for NBCn1 with 14 transmembrane domains, a long, structured N-terminal and a 
short C-terminal intracellular domain terminating in a PDZ-binding motif (-ETSL)2,12. The NBCn1 protein likely 
forms homodimers in the membrane2. The C-terminal PDZ-binding motif was found to link NBCn1 to the Na+/H+ 
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exchange regulatory factor 1 (NHERF-1, EBP50)13, the postsynaptic density protein 95 (PSD-95)14, and, indirectly, 
to the V-type H+-ATPase15 and the cystic fibrosis transmembrane regulator (CFTR)16.
Sorting of membrane proteins is a multistep process involving (i) initial sorting in the endoplasmic reticulum 
(ER), passage through the trans-Golgi Network (TGN), and insertion into correct positions in the membrane; (ii) 
membrane retention; and (iii) recycling or degradation of the membrane protein via either clathrin-dependent 
or –independent endocytosis17. Tightly controlled membrane protein sorting is pivotal for the function of epithe-
lial cells. Disturbances in the cellular polarity program are integral to the development of epithelial cancers18,19. 
Additionally, mistargeting or defective membrane localization of specific membrane proteins plays important 
roles in many diseases including cystic fibrosis20 and kidney diseases21.
Essentially nothing is known about the mechanisms of membrane targeting and sorting of NBCn1. In the 
duodenal epithelium, NBCn1 is predominantly basolateral22. In some parts of the choroid plexus, NBCn1 is 
found at the apical membrane23, and truncation of the entire C-terminal was found to abolish NBCn1 membrane 
targeting in HEK293 cells24. Thus, it appears that NBCn1 sorting mechanisms differ between different epithelial 
cells, and that at least part of the signal(s) for membrane targeting reside in the C-terminal. PDZ-binding motifs 
play important roles in sorting and retention of membrane proteins in epithelial cells25, yet truncation of the 
PDZ-binding motif did not attenuate plasma membrane NBCn1 activity in HEK293 cells26.
The kinetics and mechanisms of membrane retention, recycling and degradation of NBCn1 are poorly under-
stood. NBCn1 membrane expression in parotid acinar (ParC5) cells was reported to be very stable compared to 
that of NBCe1 (SLC4A4, an electrogenic SLC4 family member), suggesting that it is not constitutively endocy-
tosed27. However, we recently noted that upon treatment of MCF-7 breast cancer cells with the chemotherapeu-
tic drug cisplatin, NBCn1 lost its membrane localization and appeared in a punctate perinuclear localization, 
whereas the membrane localization of the Na+/H+ ion transporter NHE1 was unaltered28. This suggests the exist-
ence of distinct endocytic mechanisms for NBCn1, which can be activated under some conditions.
In this study, we identify novel aspects of the trafficking and localization of NBCn1 in epithelial cells. We car-
ried out Glutathione-S-Transferase (GST)-pulldown of the full length NBCn1 C-terminal tail, followed by mass 
spectrometry analysis (MS) to identify putative C-terminal binding partners. This revealed multiple interacting 
proteins of relevance to trafficking and membrane targeting/retention, including the small scaffolding protein 
Receptor for Activated C Kinase-1 (RACK1), which we demonstrate interacts with NBCn1 and regulates its 
Figure 1. NBCn1 localizes to the basolateral membrane in polarized MDCK-II cells. MDCK-II cells were 
cultured on Transwell filters for 4 days to allow polarization (A–D). Cells were lysed and processed for 
immunofluorescence analysis (A,B) or cell surface biotinylation followed by Western blotting (C,D).  
(A,B) fluorescence images of NBCn1 (magenta), E-cadherin (green) and ZO-1 (magenta). Nuclei stained 
with DAPI (blue). Images were collected as z-stacks on a confocal microscope and shown as z-projections 
with corresponding xz-scans. Scale bar 10 µm. (C) Representative Western blots. ß-actin was used as a loading 
control. (D) Quantification of total NBCn1 expression and NBCn1 surface expression. Values are normalized 
to the apical pool of NBCn1. Quantifications of Western blot data are shown as means with SEM error bars. 
** indicate P < 0.01. Student’s t test. Data are representative of 3 independent experiments. Ap.: apical; Bl.: 
basolateral.
www.nature.com/scientificreports/
3Scientific RepoRts |  (2018) 8:7435  | DOI:10.1038/s41598-018-25059-7
Figure 2. GFP-NBCn1 membrane localization and function. (A) GFP-NBCn1 localizes to the basolateral 
cell surface. MDCK-II cells transiently transfected with GFP-NBCn1 were cultured to 100% confluency and 
maintained in culture for 12 days before fixation. Cells were stained with wheat germ agglutinin (WGA) and 
DAPI prior to confocal imaging. Bottom rows are xz-scans of the dashed line shown in top rows (xy-scans). 
Upper and lower panel are low- and high magnification images, respectively. Scale bars: 10 µm. Representative 
images from 4 independent experiments are shown. (B,C) GFP-NBCn1 is a functional net acid extruder. 
Capacity for net acid extrusion after an NH4Cl-prepulse-induced intracellular acidification was assessed by live 
www.nature.com/scientificreports/
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membrane localization. Using Madin-Darby Canine Kidney II (MDCK-II) epithelial cells and MCF-7 human 
breast cancer epithelial-derived cells, we find that NBCn1 protein turnover was very slow, with a half-life of 
24–76 h. Finally, we show for the first time that NBCn1 is rapidly constitutively endocytosed from the basolat-
eral membrane in these cells. This work is the first detailed analysis of the kinetics and mechanisms of NBCn1 
targeting, sorting, and retrieval in epithelial cells and contributes to a broader understanding of how NBCn1 is 
regulated in these cells, which will also advance understanding of its dysregulation in diseases.
Results
Native NBCn1 localizes to the basolateral membrane in polarized MDCK-II and MCF-7 cells. 
NBCn1 has previously been shown to localize in situ to the basolateral surface of human duodenal villus cells22. 
To determine the NBCn1 localization in epithelial MDCK-II cells, cells were cultured on Transwell filters for 4 
days to allow polarization. Cells were fixed and subjected to immunofluorescence analysis of subcellular localiza-
tion by confocal imaging (Fig. 1A,B). Zona occludens protein 1 (ZO-1) and E-cadherin were used as markers of 
tight junctions (apical) and of the basolateral domain, respectively29. ZO-1 and E-cadherin showed clear localiza-
tion to the tight junction- and basolateral regions, respectively (Fig. 1B; arrowheads), suggesting proper polariza-
tion of the MDCK-II cells under these conditions. NBCn1 strongly co-localized with E-cadherin, consistent with 
its expected basolateral localization (Fig. 1A). Further, the X-Z-scan seen in Fig. 1A suggests a more lateral than 
basal localization of NBCn1. A similar pattern of NBCn1 basolateral localization was found in polarized epithelial 
MCF-7 breast cancer cells cultured on Transwell filters (Fig. S1). To substantiate that NBCn1 is indeed basolater-
ally localized, we performed separate apical and basolateral biotinylation of Transwell-polarized MDCK-II cells, 
followed by lysis, streptavidin-pull-down, and Western blotting (Fig. 1C,D). NBCn1 was exclusively detected in 
the basolateral pull-down fraction (p < 0.01; Fig. 1C,D).
These results show that NBCn1 localizes to the basolateral membrane of MDCK-II and MCF-7 epithelial cells.
Deletion of the NBCn1 C-terminal, but not of the PDZ-binding motif alone, abolishes NBCn1 
plasma membrane localization. To investigate the mechanisms involved in NBCn1 membrane localiza-
tion, we created a series of N-terminally GFP-tagged NBCn1 variants. In polarized MDCK-II cells, GFP-tagged 
full-length NBCn1 localized to the basolateral membrane in a manner undistinguishable from that of native 
NBCn1 (Fig. 2A). To verify that the exogenously expressed NBCn1 was functional, MCF-7 cells were trans-
fected with the full-length GFP-NBCn1, and 48 h later, cells were loaded with the pH sensitive fluorophore 
2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) (Fig. 2B,C). Cells were subjected to NH4Cl 
prepulse-induced acidification in the presence of HCO3−/CO2, and recovery after acidification was monitored 
in GFP-NBCn1 transfected vs parallel untransfected controls. To separate the contribution of NBCn1 from the 
sizable endogenous Na+/H+ exchanger (NHE1) activity in these cells4, experiments were conducted in absence 
or presence of the NHE1 inhibitor 5′(N-ethyl-N-isopropyl)amiloride (EIPA). In presence of EIPA, the rate of 
recovery after acidification was significantly higher in GFP-NBCn1 transfected cells, compared to untransfected 
controls (Fig. 2B,C). Taken together, these results show that the GFP-tagged NBCn1 localizes to the plasma mem-
brane and functions as a net acid extruder.
Next, we created N-terminally GFP-tagged, C-terminally deleted (∆Ct-NBCn1) NBCn1 and expressed it in 
MDCK-II cells (Fig. 2E,F) and MCF-7 cells (Fig. S2). Deletion of the C-terminal abolished plasma membrane local-
ization of NBCn1 in both cell lines. Using the online MoDPepInt motif search engine (http://modpepint.infor-
matik.uni-freiburg.de/PDZPepInt/Input.jsp) we confirmed that the last six C-terminal amino acids in NBCn1 
(-DAETSL-COOH) constitute a putative PDZ-binding motif (Fig. 2E), consistent with previous reports13. Given the 
important role of PDZ-binding motifs in protein sorting and membrane retention25 we created a deletion variant 
missing the last four amino (ETSL) acids of this putative binding domain (ΔPDZ-NBCn1) and a variant harboring a 
single T → G mutation (EGSL-NBCn1). In contrast to the deletion of the entire C-terminal tail, deletion or mutation 
of the PDZ-binding motif did not detectably alter NBCn1 plasma membrane localization (Fig. 2F).
These results show that NBCn1 plasma membrane localization is dependent on the C-terminal tail but not on 
the PDZ-binding ETSL motif. This suggests that the NBCn1 C-terminal tail harbors motifs other than the puta-
tive PDZ-binding domain which are important for NBCn1 membrane trafficking and/or localization. It remains 
possible that the PDZ binding motif is important for trafficking of NBCn1 in other contexts, and its known inter-
actions with other membrane proteins13–16 strongly suggests a role for this domain in NBCn1 organization at the 
plasma membrane.
GST-pull-down and mass spectrometry reveal multiple NBCn1 C-terminal binding candidates 
relevant for sorting, trafficking and degradation. To gain further insight into the role(s) of the NBCn1 
C-terminal in the membrane localization of the transporter, we cloned the NBCn1 C-terminal with a GST tag and 
imaging of BCECF fluorescence in GFP-NBCn1-transfected and control MCF-7 cells, in absence and presence 
of the NHE1 inhibitor EIPA. B, representative traces, C, Mean recovery rates. *p < 0.01, Student’s t-test, n = 6–10 
per condition. (D) Amino acid sequence of the human NBCn1 C-terminal tail (Met1111-Leu1214), showing 
the PDZ-binding ETSL motif in red. (E) MDCK-II cells transiently transfected with GFP-coupled full-length 
NBCn1 (GFP-NCBn1), NBCn1 with deleted C-terminal (∆Ct-NBCn1), NBCn1 with a 4-amino acid deletion in 
the putative PDZ domain (ΔPDZ -NBCn1) or NBCn1 with mutated PDZ domain (EGSL-NBCn1). Fluorescence 
images of F-actin (magenta), GFP (green). Nuclei are stained with DAPI (blue). Scale bar 10 µm. Data are 
representative of 2–3 independent experiments per construct. Corresponding data for MCF-7 cells are shown in 
Fig. S2.
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carried out GST-pull-down with the NBCn1 C-terminal in MCF-7 cell lysates, followed by mass spectrometry 
(MS) analysis to identify possible binding partners. This revealed multiple possible interaction partners with a 
robust detection ratio over GST alone (Table 1).
Several groups of proteins relevant for protein sorting, trafficking and degradation were identified (Table 1). 
Firstly, we found a large group of mediators involved in clathrin-dependent endocytosis, such as clathrin light and 
heavy chains, the adaptor protein (AP)2 complex subunits α-1, ß, and µ, and also endosomal Rab proteins such 
as Rab5A, -B, and -C as well as Rab11 and Rab8. A second group of identified proteins of interest were cortactin, 
which is important for membrane targeting of other plasma membrane proteins30, and the small scaffolding 
Gene Protein ID
C-terminal 
Intensity 106
C-terminal/
GST
Protein sorting machinery
AP2A1 AP-2 subunit alpha-1 11.0 1.3
AP2B1 AP-2 subunit beta 9.8 3.8
AP2M1 AP-2 subunit mu 16.8 4.4
CLTA Clathrin light chain A 17.4 —
CLTC Clathrin heavy chain 1 774.9 2.1
EEA1 Early endosome 1.3 2.6
Rab5A Ras-related protein 5A 42.9 —
Rab5B Ras-related protein 5B 10.4 —
Rab5C Ras-related protein 5C 173.7 —
Rab8A Ras-related protein 8A 40.0 —
Rab11 Ras-related protein 11 188.8 24.3
Scaffolding proteins
GNB2L1 RACK1 205.0 —
CTTN Cortactin 7.9 1.7
Protein degradation machinery
LAMP1 Lysosomal membrane protein 1 118.9 22.9
LAMP2 Lysosomal membrane protein 2 35.8 20.6
UBA1 Ubiquitin activating enzyme 1 (E1) 801.9 3.7
UBA6 Ubiquitin activating enzyme 6 (E1) 343.0 46.9
UBE2V1 Ubiquitin conjugated enzyme (E2) 229.2 —
UBE2N Ubiquitin conjugated enzyme (E2) 280.1 —
SYVN1 Ubiquitin ligase (E3) 1.6 —
UBR4 Ubiquitin ligase (E3) 26.3 7.6
RBX1 Ubiquitin ligase (E3) 21.5 —
HUWE1 Ubiquitin ligase (E3) 15.6 5.4
STUB1 Ubiquitin ligase (E3) 52.2 —
Retromer and WASH complex
SNX1 SNX1 7.3 6.1
SNX2 SNX2 35.3 10.9
SNX5 SNX5 13.7 —
SNX6 SNX6 44.2 13.9
VPS26a VPS26a 8.1 3.3
VPS26b VPS26b 3.6 —
VPS29 VPS29 22.4 —
VPS35 VPS35 149.2 18.8
SNX27 SNX27 84.5 157.1
KIAA0196 Strumpellin 0.9 2.3
Polarity complex
SCRIB Scribble 2.2 —
LLGL1 Lethal giant larvae 1 0.96 —
Table 1. Putative binding candidates for NBCn1 C-terminal in MCF-7 cells. Putative binding candidates for 
NBCn1 C-terminal in MCF-7 cells. The NBCn1-C-tail tagged with GST was produced recombinantly in E. coli. 
MCF-7 cells were grown to 90% confluency and lysed. NBCn1-C-GST-bound beads were added to the lysates, 
with GST-only conjugated beads and MCF-7 cell lysates with no beads as control conditions. Proteins were isolated 
and prepared for mass spectrometry, and data analysed, as described in Materials and Methods. An independent 
experiment conducted in MCF-7 cells expressing p95HER2 yielded similar results. The values listed in the table 
are intensities in millions (106). A C-terminal/GST ratio was calculated based on intensities in the C-terminal pull-
down and GST-pull-down. “–”, indicates no intensity measured for GST, thus no ratio calculated.
www.nature.com/scientificreports/
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Figure 3. RACK1 interacts with NBCn1 and is important for NBCn1 membrane localization. (A) Fluorescence 
images of NBCn1 (magenta) and RACK1 (green) in non-confluent MDCK-II cells. Nuclei are stained with 
DAPI (blue). (B) Line scan of marked yellow line in A was carried out in ImageJ and captured across the 
membrane as illustrated. (C) Fluorescence images of NBCn1 (magenta) and RACK1 (green) in confluent 
MDCK-II cells. Nuclei stained with DAPI (blue). (D) Line scan of marked line in C was carried out in 
ImageJ and captured across the membrane as illustrated. Scale bar 10 µm. (E,F) Similar data were obtained in 
MCF-7 and SKBr-3 cells (Fig. S3A,B). Proximity ligase assay (PLA) carried out in MDCK-II cells. Cells were 
treated with primary antibodies directed against NBCn1 or RACK1 or only NBCn1 as a control. A positive 
PLA signal appears as magenta dots. F-actin was stained with phalloidin-488 (green). (F) quantification 
of PLA dots was carried out in ImageJ using the analyze particles application. PLA signal in 10 randomly 
chosen cells from 10 different image areas were counted, and the average PLA signal per cell is shown in the 
www.nature.com/scientificreports/
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protein Receptor of activated protein C kinase 1 (GNB2L1, RACK1), which is involved in the trafficking, targeting 
and membrane retention of several of its binding partners31. A third group of identified putative binding partners 
comprised components of the protein degradation machinery, including Lamp-1 and -2, and several E1-, E2-, and 
E3- ubiquitin-conjugated enzymes, including at least five E3 ubiquitin ligases: SYVN1, UBR4, RBX1, HUWE1 
and STUB1. Finally, we found a large fraction of the components of the retromer and WASH complex, which 
is involved in protein recycling from endosomes to the Trans-Golgi network or back to the cell surface, respec-
tively32. Retromer components identified included sorting nexin SNX-1, -2, -5, -6 and vacuolar protein sorting 
VPS-26a/b, -29 and -35. Components from the WASH complex included SNX27 and Strumpellin (Table 1).
Taken together, the GST-pull-down and MS analysis revealed multiple novel NBCn1 C-terminal binding can-
didates of putative importance for the sorting, trafficking, membrane retention and degradation of NBCn1.
RACK1 interacts with NBCn1 and is important for its plasma membrane localization. A major 
interaction candidate revealed by the MS analysis was RACK1 (Table 1), which is known to play important roles in 
protein targeting and membrane retention31,33–37. Therefore, we hypothesized that RACK1 contributes to NBCn1 
membrane targeting and/or retention. To test this, we first carried out immunofluorescence analysis of native 
NBCn1 and RACK1 to identify regions of co-localization of the two proteins. In non-confluent MDCK-II cells, 
NBCn1 and RACK1 both appeared to localize throughout the cell, and strong co-localization was evident par-
ticularly in leading edge lamellipodia (Fig. 3A,B). Remarkably, this distribution was altered in confluent MDCK-II 
cells: Under confluent conditions, NBCn1 was almost exclusively membrane-localized, while RACK1 exhibited a 
punctate, cytoplasmic localization (Fig. 3C,D). A similar pattern was observed in MCF-7 cells and in SKBr-3 breast 
cancer epithelial cells (Suppl. Fig. S3A,B), suggesting that this is a general phenomenon in epithelial cells.
Cellular interaction between NBCn1 and RACK1 was substantiated by in situ proximity ligase assay (PLA), 
an antibody-based assay that can detect close interaction (intermolecular distance < 40 nm) between two natively 
expressed proteins38. Demonstrating close proximity between the two proteins, non-confluent cells incubated 
with both NBCn1 and RACK1 primary antibodies showed a PLA signal about 8-fold above the control exposed 
to only NBCn1 antibody, both in MDCK-II (Fig. 3E,F) and MCF-7 cells (Fig. S3C,D). To determine whether this 
reflected physical interaction between the two proteins, we performed native co-immunoprecipitation (co-IP) 
between NBCn1 and RACK1 in confluent and non-confluent (70% confluency) MDCK-II cells (Fig. 3G,H). 
NBCn1 was able to precipitate RACK1 (Fig. 3G) and vice versa (Fig. 3H) in non-confluent cells, confirming their 
physical interaction. In some cases, however, Rack1 was able to precipitate NBCn1 also in confluent cells (data 
not shown). We finally asked whether RACK1 was important for the plasma membrane localization of NBCn1. 
A cell surface biotinylation assay was used to determine the surface fraction of NBCn1 following transfection of 
MCF-7 cells with two different siRNAs targeting RACK1 (Fig. 3I,J). RACK1 knockdown cells elicited a significant 
reduction of the NBCn1 surface fraction, comparable in magnitude to the reduction in RACK1 protein level, yet 
did not alter the total cellular NBCn1 protein level.
In order to determine which part of the NBCn1 C-tail interacted with RACK1, we designed a deletion series 
of FLAG-tagged C-tail constructs, spanning from the full C-tail (137 amino acids) to the most proximal 22 amino 
acids (Fig. 4A). The constructs were expressed in HEK-293 cells, as validated by immunofluorescence analysis 
and Western blotting for FLAG (Fig. 4B,C). Lysates from the transfected cells were subjected to FLAG co-IP fol-
lowed by blotting for RACK1. As seen, all four constructs pulled down RACK1 to a greater extent than that seen 
with control transfections (sham, IgG ctrl., and empty vector) (Fig. 4D,E).
Collectively, these results show that RACK1 physically interacts with NBCn1, that the most proximal part of 
the NBCn1 C-tail is sufficient for this interaction, and that NBCn1 and RACK1 co-localize most prominently in 
non-confluent cells. Furthermore, RACK1 knockdown is associated with reduced NBCn1 surface expression, but 
not with changes in its total expression level.
NBCn1 undergoes rapid constitutive internalization in MDCK-II cells. The results from the MS 
analysis suggested that the NBCn1 C-terminal region interacts with multiple proteins involved in endocytosis, 
including several components of the clathrin-mediated endocytosis pathway, such as the AP-2 complex, clathrin 
itself and Rab5 (Table 1). We therefore next asked whether NBCn1 is constitutively internalized in polarized 
MDCK-II cells. Cells were grown on Transwell filters for 4 days to allow polarization. Proteins accessible from 
the basolateral cell surface were labeled with cell-impermeable biotin at 4 °C. Cells were subsequently incubated 
at 37 °C under standard cell culture conditions to allow internalization for 0 (control), 5, 15, 30, 60 and 360 min. 
Total surface biotin labeled proteins were detectable only at the (baso)lateral membrane confirming that bioti-
nylation was specifically basolateral (n = 3, data not shown). Subsequent to internalization, remaining biotin 
was stripped from surface proteins to allow specific tracing of internalized protein, and samples were subjected 
to streptavidin pulldown to isolate biotinylated proteins, corresponding to internalized proteins. To evaluate 
bar graph. Data are representative of 3 independent experiments and shown as mean with SEM error bars. 
****P < 0.0001, Student’s t test. Similar data were obtained in MCF-7 cells (Fig. S3C,D). (G,H) Native co-IP 
of NBCn1 and RACK in non-confluent (~70% confluency) MDCK-II cells. Cells were lysed and subjected to 
pull-down with either antibody against NBCn1 (G) or against RACK1 (H), or the appropriate isotype control, 
followed by Western blotting of the pull-down and input fractions as shown. Representative of 4 independent 
experiments. (I,J) The surface fraction of NCBn1 in MCF-7 cells was examined by biotinylation after RACK1 
knockdown using two different siRNAs. I: representative Western blots. ß-actin was used as a loading control. 
J: quantifications of RACK1 and NBCn1 protein expression normalized to mock control. **,***P < 0.01 and 
0.001 vs. scrambled (Scr), respectively, ns: non-significant. n = 3.
www.nature.com/scientificreports/
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internalized NBCn1 at the different time points, pulldown samples (internalized proteins) were subjected to 
Western blotting against NBCn1. Following 15 min of internalization at 37 °C, an increased level of internalized 
NBCn1 protein was detectable by Western blotting, demonstrating that NBCn1 is internalized from the basolat-
eral membrane already at this time (Fig. 5A,B). NBCn1 internalization reached peak levels around 30–60 min 
after transfer to 37 °C. This was followed by a reduction in detectable biotinylated NBCn1, reaching approximately 
the 0 min level at time point 360 min, and presumably reflecting protein degradation.
These results show that NBCn1 undergoes rapid constitutive endocytosis in polarized MDCK-II epithelial cells.
Total cellular NBCn1 turnover is slow and dependent on lysosomal function. Our recent findings 
indicated that NBCn1 protein turnover is slow in MCF-7 cells9, however, the exact half-life of the transporter and 
the mechanism of degradation were not determined. To address this, MCF-7 cells were exposed to 100 µg/ml 
Figure 4. RACK1 interaction with FLAG-NBCn1 deletion constructs. (A) Overview of NBCn1 organization 
and the four FLAG-tagged NBCn1 constructs employed. HEK293 cells were transiently transfected with one 
full length (137) and three truncated (22, 41 and 122) FLAG-tagged versions of the NBCn1 C-terminal prior to 
lysis or PFA fixation after 24 h incubation. (B) Fixed cells were prepared for immunofluorescence microscopy 
using antibodies directed against the most distal C-terminal amino acids in NBCn1 (NBCn1 C-term) or FLAG. 
Scale bars: 20 µm. (C) Samples from lysed cells were subjected to SDS-PAGE and Western blotting against 
FLAG and β-actin (loading control). (D) Samples from lysed cells were subjected to FLAG IP and analyzed 
by SDS-PAGE and Western blotting against RACK1 and p150 (loading control). Ctrl: isotype control. Sham: 
sham-transfected cells. (E) HEK293 cells were transfected with empty vector pFLAG-CMV-2 (EV) or full length 
NCBn1 C-terminus (137) and lysed before performing IP against FLAG and analyzing by SDS-PAGE and 
Western blotting against RACK1 and β-actin (loading control). Representative images from 3–4 independent 
experiments are shown.
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cycloheximide (CHX) to arrest protein synthesis, and NBCn1 protein levels were determined at 8 time points 
from 0–96 h after CHX addition (Fig. 6A,B). In cells not exposed to CHX (solid line, Fig. 6B), the NBCn1 protein 
level was significantly increased after 6 h and continued to increase for the first 48 h. Cyclin B1 was used as a pos-
itive control due to its rapid protein turnover39. As expected, Cyclin B1 was rapidly degraded with an estimated 
half-life of less than 3 h. In contrast, NBCn1 degradation was much slower, with an estimated half-life of 76 h 
(Fig. 6B). NBCn1 degradation was also slower than that of NHE1, another pH-regulatory membrane protein, the 
half-life of which has previously been estimated to 24–48 h (Fig. S4A,B)40. At time points later than 48 h, CHX 
treatment elicited modest but detectable poly ADP-ribose polymerase (PARP) cleavage (Fig. S4C). However, this 
is unlikely to affect NBCn1 expression data, which was always normalized to total protein expression and β-actin 
loading controls.
We previously reported that the proteasome inhibitor MG132 did not affect degradation of total cellular 
NBCn1, arguing against a detectable contribution from proteasomal degradation to NBCn1 turnover10. We there-
fore hypothesized that NBCn1 is primarily degraded in the lysosomal compartment. Co-immunofluorescence 
analysis of NBCn1 and the lysosomal membrane protein LAMP1 revealed extensive co-localization between 
NBCn1 and LAMP1 in MCF-7 cells (Fig. 6C). Further, co-treatment with concanamycin A (which inhibits the 
lysosomal H+ V-ATPase and hence lysosomal function) over a period of 0–96 h blocked the loss of NBCn1 pro-
tein after CHX treatment (Fig. 6D,E). Similar findings were obtained in MDCK-II cells (Fig. S5), supporting the 
generality of this mechanism.
These results show that NBCn1 turnover proceeds with a half-life of approximately 76 h, and suggest that 
NBCn1 is predominantly degraded in the lysosomes.
Discussion
Despite the well described physiological roles of NBCn11,2 and the fact that dysregulation of NBCn1 contributes 
to the development of several human malignancies, including breast cancer1,7,8, the kinetics and mechanisms of 
sorting, recycling, localization and degradation of NBCn1 are largely unexplored. This work provides the first 
analysis of NBCn1 targeting, sorting and degradation in epithelial cells.
In renal medulla, duodenum and exocrine gland epithelial cell types2,22,27,41, with the exception of a small part 
of the choroid plexus epithelium42, NBCn1 localizes to the basolateral membrane. As expected, this was also the 
case in polarized MCF-7 and MDCK-II cells. Deletion of the NBCn1 C-terminal abolished the plasma membrane 
localization of NBCn1, confirming findings by Loiselle and co-workers24. We note, however, that NBCn1 is found 
predominantly in the lateral compartment rather than evenly distributed throughout the basolateral membrane 
and our MS analyses suggest multiple lateral interaction partners (e.g. Scribble and Lethal giant larvae 1).
A key finding of this study is that NBCn1 interacts with the scaffold protein RACK1, a finding supported 
by in situ PLA, reciprocal native co-IP, and pulldown of RACK1 with FLAG-tagged NBCn1 C-tail constructs. 
Although the precise minimal interaction motif was not identified, the most proximal part of the NBCn1 C-tail 
was sufficient for the interaction with RACK1. RACK1 interaction motifs are diverse and many interactions 
occur with multiple WD repeats and involve either a relatively small, specific motif, or a complex interaction 
over an extended surface43. In this context it is notable that the proximal part of the NBCn1 tail is predicted to 
Figure 5. NBCn1 is rapidly endocytosed from the basolateral membrane. MDCK-II cells were cultured on 
Transwell filters for 4 days and basolateral surface expressed proteins were labeled with cell impermeable biotin 
at 4 °C. Internalization was carried out at 37  °C, followed by stripping of biotinylated proteins still exposed at 
the cell surface. Cells were lysed and analyzed by Western blotting at the times indicated. (A) Representative 
Western blots of the total lysate fraction (top) and internalized (bottom) NBCn1. ß-actin was used as a loading 
control. TS: Total surface expression, TLF: total lysate fraction. For the 0 min time point, stripping off surface 
biotin was performed immediately after biotinylation. (B) Internalized NBCn1. Quantification of C showing 
mean raw densitometry (+SEM) of three independent experiments in arbitrary units (AU). *p < 0.05 One-way 
ANOVA with Dunnett’s post-hoc test (0 min is control column).
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Figure 6. Protein turnover of NBCn1 is very slow. MCF-7 cells were cultured for 48 h prior to exposure to 
100 µg/ml cycloheximide (CHX)+/− 10 nM concanamycin A (ConA) for the indicated time. Cells were 
lysed and processed for Western blotting (A,B and D,E) or fixed for immunofluorescence analysis (C). (A,D) 
Representative Western blots. ß-actin was used as a loading control and Cyclin B1 was used as a positive control 
for protein synthesis inhibition. (B,E) Protein turnover rate for NBCn1 after exposure to CHX+/− ConA. 
Values are normalized to 0 h for each exposure. (C) Fluorescence images of NBCn1 (magenta) and LAMP1 
(green). Nuclei are stained with DAPI (blue). Scale bar 5 µm. Data are representative of 3–5 independent 
experiments. Western blot data are shown as mean with SEM error bars. *: comparison of values under the 
same treatment; #: comparison of values at the same condition but subjected to different exposures. */#, **/##, 
***/### and ****/#### indicate P < 0.05, P < 0.01, P < 0.001 and P < 0.0001 respectively, relative to the initial 
value for that group (stars) or to the corresponding non-CHX-treated controls at the same time point (hash-
tags). Two-way ANOVA with Bonferroni post-test. Similar data were obtained in MDCK-II cells (Fig. S5).
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be helical in nature (https://predictprotein.org/), and the RACK1-interaction domain on the cyclic AMP spe-
cific phosphodiesterase, PDE4D5, was proposed to be an amphipatic helix44. RACK1 knockdown reduced the 
cell surface expression of NBCn1, yet not its total cellular expression. This is in congruence with several studies 
demonstrating the importance of RACK1 for the surface expression of other membrane transporters and recep-
tors34–37,45. Thus, the NBCn1-RACK1 interaction is important for NBCn1 surface expression and hence for the 
cellular capacity for net acid extrusion. Importantly, the marked co-localization of RACK1 and NBCn1 observed 
in motile, non-confluent MDCK-II cells was abolished (or undetectable) in fully polarized cells, indicating that 
the complex of proteins interacting with NBCn1 is dynamic and differs between stable polarized epithelial sheets 
and cells with a more mesenchymal phenotype. In congruence with our observations, the Thromboxane A2 
receptor and RACK1 localized predominantly to the plasma membrane and in cytoplasmic puncta, respectively36, 
yet RACK1 played an important role in the membrane trafficking of the receptor, by a mechanism proposed to 
involve a transient interaction with RACK1 in the ER36. Thus, we suggest that NBCn1 trafficking to its lateral 
localization during apico-basal polarization of epithelial cells involves its RACK1-dependent trafficking from the 
ER to the leading edge, followed by formation of a new NBCn1 complex at the membrane which does not involve 
RACK1. In agreement with such a model for the function of RACK1, the transmembrane protease ADAM12 
localized mainly intracellularly in subconfluent cultures, and under these conditions, RACK1 was important for 
its PKC-dependent membrane translocation45. Finally, the BKCa channel was shown to interact with RACK1 by 
co-IP and GST-pulldown, but only a fraction of the channels and RACK1 co-localized in the plasma membrane46. 
While not studied here, the role of RACK1 in trafficking of other membrane proteins to the plasma membrane 
has been proposed to involve PKC-36,45 and dynamin-36 dependent mechanisms.
An unexpected finding of the present work, confirmed in both MCF-7 and MDCK-II cells, was that while the 
NBCn1 a space was missing here C-terminal tail was required (consistent with previous work,24), the PDZ bind-
ing domain at the distal end of the C-terminal was not required for membrane targeting of the transporter. This 
domain may nonetheless play a role in transporter recycling, since another prominent binding partner identified 
here was the retromer trafficking protein sorting nexin 27 (SNX27), which was recently shown to interact with 
NBCn1 in a PDZ-dependent manner47. Candidate regulators of basolateral sorting of NBCn1 identified in our 
MS analysis include the small GTPase Rab8 and Rab11. Several putative membrane sorting motifs are found in 
the NBCn1 C-terminal and ongoing work in our laboratory addresses the specific motifs and interactors involved 
in basolateral NBCn1 sorting and recycling.
By following the internalization of the pool of biotin labeled surface NBCn1 protein in MDCK-II cells we 
found that NBCn1 was rapidly internalized to a detectable level already after 15 min. After 360 min, the level 
of internalized NBCn1 was similar to control levels (0 min internalization). The rapid internalization and 
long half-life could reflect a fast and continuous NBCn1 recycling but further studies are needed to elaborate 
this speculation. A fast internalization rate is also seen for many other membrane transporters, including the 
Na+-Cl− co-transporter, NCC (SLC12A3)48 and the Na+-H+ exchanger NHE3 (SLC9A3)49. Both undergo rapid 
clathrin-dependent endocytosis from the apical membrane as part of the dynamic regulation of their activity at 
the plasma membrane, whereas constitutive internalization of the basolateral NHE1 is substantially slower, with 
only 15% internalized after 3 h50. In contrast to our findings, a lack of detectable NBCn1 internalization was 
reported for NBCn1 in rat parotid gland acinus-derived ParC5 cells, while the electrogenic NBCe1 (SLC4A4), 
which shares 50% sequence similarity with NBCn1, was found to undergo clathrin-mediated endocytosis within 
60 min27. It seems reasonable to speculate that the major differences between acinar cells and ductal epithelial 
cells may underlie the apparent contrast in endocytic properties, and this may suggest important differences in 
NBCn1 regulation in the two settings.
Using CHX to block de novo protein synthesis, we determined the half-life of NBCn1 protein degradation 
in MCF-7 cells to be 76 h. This confirms our recent finding that NBCn1 protein degradation is very slow10. The 
co-localization of NBCn1 with the lysosomal marker Lamp-1, and the fact that inhibition of the lysosomal 
V-ATPase inhibited NBCn1 degradation, suggests that NBCn1 degradation is predominantly lysosomal. This 
is in congruence with our previous finding that proteasomal inhibition has no effect on NBCn1 protein deg-
radation10 and fits well with the detection of NBCn1 in the lysosomal proteome51. It is also consistent with the 
observation that lysosomal NBCn1 abundance was increased upon expression of p95HER251, which is associ-
ated with greatly increased NBCn1 expression4,9. It remains possible that specific signaling pathways addition-
ally stimulate NBCn1 internalization under certain regulatory conditions. Supporting this notion, we recently 
showed that upon cisplatin-induced cell death in MCF-7 breast cancer cells, NCBn1 was lost from the plasma 
membrane and appeared in a perinuclear compartment within 18 h, whereas NHE1 remained at the cell surface28. 
Five lysines in the human NBCn1 C-terminal, K1144, K1151, K1183, K1186, and K1206, have been shown to 
be ubiquitinated52. Consistent with this, our MS analysis identified several E3 ubiquitin ligases: SYVN1, UBR4, 
RBX1, HUWE1, and STUB1 (CHIP), as putative NBCn1 C-terminal interaction partners. At least four of these E3 
ligases have been assigned roles in the degradation of ion transport proteins53–56, and could be relevant candidates 
for NBCn1 ubiquitination. It thus seems likely that ubiquitination is a means to regulate NBCn1 internalization 
and degradation, as seen e.g. for the epithelial Na+ channel ENaC and the Na+/H+ exchanger NHE150,57. Given 
the robust upregulation of NBCn1 in some epithelial cancer cells6–8, it is also interesting in this regard that one of 
the identified E3 ligases is STUB1, a tumor suppressor protein in several human cancers58. Clathrin and the AP2 
clathrin-adaptor complex were also identified as possible NBCn1 C-terminal binding partners in our MS anal-
ysis, and may contribute to the ubiquitination-dependent internalization and lysosomal targeting of NBCn159. 
The regions of potential interaction with AP2 were not studied here, but the NBCn1 C-terminal tail contains two 
classical di-hydrophobic such motifs (1165DDTVHL1170 and 1173EGGSLL1178), as well as two long basic stretches 
1142KKKK1145 and 1149KKKK1152 which could act as non-canonical AP2 interaction motifs60,61.
In conclusion, here we identified a series of potential C-terminal NBCn1 binding partners, of which we 
demonstrated that the scaffold protein RACK1 interacts with NBCn1 and is important for its surface expression 
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and hence net acid extrusion activity. While the NBCn1 C-terminal tail is required for its membrane localization, 
the PDZ-binding motif in its most distal end is dispensable for this process. Furthermore, we show that NBCn1 
undergoes rapid constitutive endocytosis. In contrast, total NBCn1 protein turnover is very slow, with a half-life 
of about 76 h in MCF-7 epithelial cells, suggesting extensive recycling of the transporter protein. This work reveals 
novel aspects of the sorting, targeting, and degradation of NBCn1 and can contribute to a broader understanding 
of how NBCn1 is regulated in epithelial cells under normal and pathological conditions.
Materials and Methods
Antibodies and reagents. The polyclonal antibody directed against the N-terminal of NBCn1 was kindly 
provided by Jeppe Prætorius, Aarhus University, Denmark. Antibodies against ZO-1 (sc-10804), and GFP (sc-
8334) were from Santa Cruz Biotechnology, Texas, USA. Antibodies directed against RACK1 (#610177 and 
#A2560) and E-cadherin (#610181) were from BD Transduction Laboratories, San Jose, USA and ABclonal, 
Woburn, USA, antibody against Cyclin B1 (#12231) was from Cell Signaling Technology, Danvers, USA, and 
antibodies against biotin (#B3640) and ß-actin (#A5441) and FLAG M2 (#F1804) were from Sigma-Aldrich, St. 
Louis, USA. Cycloheximide (#C7698) and Concanamycin A (#C9705), both from Sigma-Aldrich, were dissolved 
at 5 mg/mL in ddH2O and 10 µM in DMSO, respectively.
Cell lines and culture conditions. MCF-7 cells were cultured in DMEM 1885 supplemented with 5% 
fetal bovine serum (FBS), 1% penicillin/streptomycin and 1% non-essential amino acids. MDCK-II cells were 
cultured in alpha modified MEM (α-MEM) supplemented with 10% FBS, 1% penicillin/streptomycin and 2 mM 
L-Glutamine. SKBr-3 and HEK293 cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/
streptomycin. All cell lines were maintained at 37 °C, 95% humidity and 5% CO2. MCF-7 and MDCK-II cells 
were grown in culture dishes or, where indicated, grown for 4 days on Transwell polycarbonate filters (Corning 
Incorporated (Costar), Sigma-Aldrich, #3401 and #3412) with 0.4 µm pore size.
GFP-tagged NBCn1 constructs. GFP-constructs. Rat NBCn1 (rNBCn1-D, NM_058211.2) was ampli-
fied by PCR from cDNA in plasmid kindly provided by Dr. Ebbe Boedtkjer (Aarhus University, Denmark). 
Amplified rNBCn1-D was inserted into a pEGFP-C1/Kan/Neo vector using the restriction enzymes BglII and 
KpnI (recognition sites shown in bold non-capital letters in the primers) (New England Biolabs) to produce the 
N-terminally GFP-tagged rNBCn1-D. Four different variations were made: Full-length NBCn1 (GFP-NBCn1); 
NBCn1 with the four C-terminal amino acids of the PDZ motif (ETSL) deleted (ΔPDZ-NBCn1); NBCn1 
with a mutated PDZ motif (EGSL-NBCn1); and NBCn1 lacking the entire C-terminal tail (∆C-NBCn1). 
Primers used were: FW (All Constructs): 5′GATAagatctATGGAGGCAGACGGGGCCGG′3; RV (GFP-NBCn1): 
5′AATGGTACCggtaccTTACAATGAAGTTTCAGCATCCATGTATTTTTTTG′3; RV (ΔPDZ-NBCn1): 
5′AATGGTACCggtaccTTAGCGCACAAAGACTAATGCAAGAACC′3; RV (EGSL-NBCn1): 5′AATGGTAC 
CggtaccAGCATCCATGTATTTTTTTGATGGTTCATC′3; RV (ΔCt-NBCn1): 5′AATGGTACCggtaccC 
AATGAACCTTCAGCATCCATGTATTT′3.
Plasmids were transiently expressed in MDCK-II or MCF-7 cells using lipofectamine 3000, according to the 
manufacturer’s instructions. The following day, cells were fixed and subjected to immunofluorescence analysis as 
described below.
Analysis of NBCn1 half-life. To estimate protein half-life of NBCn1, 100 µg/ml cycloheximide (CHX) and/
or10 nM Concanamycin A (ConA) was added 48 h after seeding of MDCK-II or MCF-7 cells in Petri dishes. Cells 
were subsequently incubated for the indicated amount of time before they were lysed and analyzed by Western 
blotting as described below.
Immunofluorescence analysis. Cells were washed in cold phosphate-buffered saline (PBS; 137 mM NaCl, 
2.7 mM KCl, 8.1 mM Na2HPO4-2H2O and 1.5 mM KH2PO4), fixed for 30 min at 4 °C in 4% paraformaldehyde 
(PFA, Sigma-Aldrich, #47608) and washed in PBS. Cells were permeabilized in 0.5% Triton-X-100 (Plusone, 
#17-1315-01) for 10 min and blocked in 5% Bovine Serum Albumin (BSA, Sigma Aldrich #A7906) for 30 min. 
Primary antibodies were added over night at 4 °C and secondary antibodies for 1 h at room temperature. Cells 
were treated with DAPI (Invitrogen, Waltham, USA, #C10595) for 5 min to stain nuclei, washed in 1% BSA 
and mounted in 2% N-propyl-galleate (Sigma-Aldrich, #P-3130) in PBS/glycerine. Images were collected on an 
Olympus BX63 upright microscope with a 60 ×/1.35 NA oil objective using Olympus CellSens dimension soft-
ware or (confocal images) on a Leica SP 5 × MP confocal laser scanning microscope with a 40 × or 60 ×/1.3 NA 
oil objective using Leica LAS AF software. Z-stacks were captured in intervals of 0.2 µm with corresponding 
Z-scans. Images were processed in ImageJ. No labeling was detectable in the absence of primary antibody at the 
settings used (data not shown).
Cell surface biotinylation assay. To determine the surface fraction of NBCn1, MDCK-II cells were cul-
tured on Transwell filters for 4 days in order to allow polarization. Cells were incubated for 30 min at 4 °C with 
freshly made 0.2 mg/ml cell impermeable EZ-Link Sulfo-NHS-SS-Biotin (Life Technologies, #21331) diluted in 
PBS added to either the basolateral or apical side of the filters as indicated. Removal of excess biotin was done 
by several washing steps in cold quenching buffer (0.1 M glycine in PBS). Cells were lysed in cold RIPA buffer 
(150 mM NaCl, 50 mM Tris HCl pH 7.5, 0.1% SDS, 0.5% Sodium deoxycholate, 1% Igepal CA630 and CompleteTM 
mini protease inhibitor). Samples were centrifuged for 15 min at 16.000 RCF and 4 °C, and the supernatant was 
adjusted to equal amounts of protein (DC assay, BioRad). A small fraction of the supernatant was dissolved in 
4 × LDS sample buffer and saved as the Total Lysate Fraction (TLF). The remaining supernatant was incubated 
with prewashed streptavidine-conjugated agarose beads (Sigma-Aldrich, #S1638) for 2 h with gently rolling at 
4 °C. Samples were washed several times in cold RIPA buffer, dissolved in 2 × LDS sample buffer and heated for 
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5 min at 95 °C. Beads were pelleted by centrifugation at 4 °C for 4 min at 2000 RCF and the supernatant was saved 
as the Pull-down (PD) fraction. Samples were processed for Western blotting as below.
SDS-PAGE and Western blotting. Cells were lysed in 95 °C pre-heated SDS lysis buffer (0.1 M Tris-HCl 
pH 7.5, 10% SDS, 1 mM Na4VO3 and CompleteTM protease inhibitor mix (Roche)). Protein concentrations were 
determined by DC assay (BioRad, Hercules, USA) and samples were mixed with NuPage LDS sample buffer 
(Invitrogen, #NP0007). Equal amounts of protein were separated by SDS-PAGE using CriterionTM 10% tris gels 
(Bio-Rad, 18 wells, #567-1034 and 26 wells, #567-1035) and premade Tris/Glycine/SDS running buffer (BioRad, 
#161-0732), and BenchMark protein ladder (Invitrogen, #10747-012). Proteins were transferred by Trans-Blot 
Turbo transfer system (BioRad) to a PVDF membrane (BioRad, #170-4159), stained with Ponceau S and blocked 
in 5% nonfat dry milk in TRIS-buffered saline with Tween (TBS-T; 0.01 M Tris/HCL, 0.15 M NaCl, 0.1% Tween 
20, pH 7.4) for 1 h at 37 °C. Membranes were incubated with primary antibodies diluted in 5% nonfat dry milk in 
TBS-T overnight at 4 °C and with horseradish peroxidase (HRP) conjugated secondary antibodies in 5% nonfat 
dry milk in TBS-T for 1 h at room temperature. Bands were visualized by chemiluminescent using enhanced 
chemiluminescent (ECL) substrate (Pierce, #32106). Densitometric analyses were carried out using ImageJ.
Glutathione-S-Transferase (GST)-pulldown and mass spectrometry analysis. The NBCn1 
C-terminal was amplified from a pcDNA5 plasmid containing full length rat NBCn1-D using the primers: FW: 
5′TAggatccGTGGCGAGGCTCATGGAT′3 and RV: 5′GACGgaattcTTACAATGAAGTTTCAGC′3) and inserted 
with BamHI (FW) and EcoRI (RV) restriction enzymes (shown in bold non-capital letters) at the C-terminal of 
the GST gene under the control of a lactose operon in a pGEX-2T vector containing. The plasmid was expressed 
in E. coli, and protein synthesis of the NBCn1 C-terminal-GST (NBCn1-C-GST) construct was initiated by add-
ing 1 mM isopropyl ß-D-thio-galactoside (IPTG, Sigma-Aldrich, #11284) followed by overnight incubation 
at 4 °C under gently shaking. IPTG-induced bacteria were spun down for 13 min at 2800 RCF and the pellet 
re-suspended in cold PBS supplemented with protease inhibitor mix (Roche). Samples were sonicated and centri-
fuged for 20 min at 20.000 RCF and added to a Bio-rad poly-prep chromatography column (Bio-Rad, #731–1550) 
containing glutathione agarose beads (Life Technologies, Waltham, USA, #G2879) washed in PBS supplemented 
with 0.05% Triton-X-100. The NBCn1-C-GST-bound beads were collected and stored in 100% glycerol at −80 °C. 
MCF-7 cells were cultured to 90% confluency, lysed in cold PBS, trypsinized and centrifuged at 50 RCF. Pellet 
were re-suspended in cold GST-lysisbuffer (80 mM Tris-HCl pH 7.5, 200 mM NaCl, 1% Triton-X-100 and pro-
tease inhibitor mix (Roche)), sonicated and protein concentration was measured by DC assay (Bio-Rad). Washed 
NBCn1-C-GST-bound beads were added to the lysates. GST-only conjugated beads and MCF-7 cell lysates with 
no beads were used as controls. The bead-lysate mixes were incubated for 2 h at 4 °C with gentle rolling, washed 
several times in wash buffer (20 mM Tris HCl pH 7.5, 150 mM NaCl, 1 mM DTT and 0.05% Triton-X-100), and 
adjusted to 10 µg/µl with wash buffer. To prepare samples for mass spectrometry, proteins were separated on 
Bis-TRIS gels followed by Coomassie staining, excision, protein digestion with trypsin and protein desalting to 
avoid interference of ions with the mass spectrometry analysis. The digested protein fragments were analyzed by 
HPLC coupled LTQ Orbitrap mass spectrometry62. Mass spectrometric analysis was performed by LC-MS using 
an Easy-LC system (Thermo) and an LTQOrbitrap or Q-Exactive mass spectrometer (Thermo Fisher). The raw 
data files were processed using MaxQuant (version 1.3.05)63. Data were blasted against Uniprot (http://www.
uniprot.org/) human proteome dataset (release 2013_01, 87613 sequences) using the Andromeda search engine64.
In situ proximity ligation assay (PLA). Proximity between NBCn1 and RACK1 was detected using the 
Duolink II Detection Reagents Red kit (Sigma Aldrich, #DUO92004) according to the Manufacturer’s instruc-
tions. Briefly, MCF-7 and MDCK-II cells were seeded on coverslips 48 h prior to assaying to allow 60–70% conflu-
ency. Cells were washed in cold PBS, fixed for 30 min in 4% PFA on ice, washed in Duolink II Buffer A, quenched 
for 15 min in 0.1 M glycine in PBS, permeabilized in 0.5% Triton-X-100 and washed in Buffer A. Cells were 
blocked in O-link blocking solution for 30 min, incubated with primary antibodies for 1 h and with PLA probes 
diluted 1:5 for 1 h, both at 37 °C. Cells were washed in Buffer A and incubated with ligation solution for 30 min, 
and amplification solution for 100 min, both at 37 °C. Preparations were incubated with Alexa-488-conjugated 
phalloidin (Invitrogen, #A12379) for 1 h to stain F-actin, and were finally washed in Buffer A, treated with DAPI 
for 5 min to stain nuclei, washed in ddH2O and mounted using 2% N-propyl-galleate in PBS/glycerine mounting 
medium. Images were collected on an Olympus BX63 upright microscope with a 60 ×/1.35 NA oil objective using 
Olympus CellSens dimension software. Z-stacks were captured in intervals of 0.7 µm and processed in ImageJ. 
Quantification of the PLA dots were carried out in ImageJ by using ROI manage and the “Analyze particles” 
functions.
Live imaging of intracellular pH. MCF-7 cells were seeded in WillCo glass bottom dishes (WillCo Wells, 
Amsterdam, The Netherlands, #3522) and transfected with full-length GFP-NBCn1-D or left untransfected 
(control cells). Cells were incubated in growth medium containing 2.5 µM 2′,7′-bis-(2-carboxyethyl)-5-(and-
6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM Invitrogen #B1150) for 30 min at 37 °C, followed by 
transfer to HCO3− containing Ringer solution (118 mM NaCl, 25 mM NaHCO3, 5 mM KCl, 1 mM MgSO4, 1 mM 
Na2HPO4, 1 mM CaCl2, 3.3 mM MOPS, 3.3 mM TES, 5 mM HEPES, adjusted with NaOH to pH 7.4 at 37 °C). 
GFP fluorescence was negligible compared to the BCECF fluorescence, and did not interfere with pHi measure-
ments. The pHi recovery was assessed by using the NH4+-prepulse technique: after a 5 min baseline phase, cells 
were exposed to 20 mM NH4Cl in the same NaHCO3 containing saline, for 10 min. Removal of NH4Cl leads to a 
rapid acidification, the initial slope of recovery from which is the rate of net acid extrusion. Recovery was assessed 
in absence or presence of 10 µM EIPA to inhibit Na+/H+ exchange. pHi was measured using a Nikon Eclipse Ti 
microscope equipped with a Xenon lamp, a 40 × oil, 1.4 NA objective and EasyRatioPro imaging software (PTI, 
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NJ,USA). The excitation wavelengths alternated between 440 nm and 485 nm, and emission was measured at 
520 nm. The BCECF ratio was calculated from the fluorescence intensities measured at 485 nm/440 nm after 
correction for background fluorescence. Calibration was carried out using the high K +/nigericin technique65, 
employing KCl solutions (156 mM KCl, 1 mM MgSO4, 1 mM CaCl2, 1 mM K2HPO4, 3.3 mM 3-(-N-morpholino)
propanesulfonic acid (MOPS), 3.3 mM 2-[Tris(hydroxymethyl)-methylamino]-ethanesulfonic acid (TES), 5 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)) of pH 6.6, 7.0, 7.4 and 7.8, and 5 µM Nigericin 
(Sigma-Aldrich, Cat.# N-7143).
Native co-immunoprecipitation of NBCn1 and RACK1. MDCK-II cells were seeded in 10 cm Petri 
dishes, washed twice in PBS and lysed with room temperature lysis buffer (50 mM Tris pH 7.4, 140 mM NaCl, 
3 mM Na3VO4, 1% v/v IGEPAL CA-630 (Sigma, cat. #I8896), Phosphatase Inhibitor cocktail (PhosStop) (Roche, 
cat. #04906845001), Protease Inhibitor cocktail (Roche, cat. #11697498001). Protein content was normalized 
to a concentration of 3–4 mg/mL in 500 μL. Samples were incubated with primary antibodies at 4 °C overnight 
with gentle rotation: antibody against the NBCn1 N-terminal (kindly provided by Prof. Jeppe Praetorius, Aarhus 
University) 2 μL/mg protein, antibody against RACK1 (BD Biosciences, cat. #610177) 1.25 μg/mg protein, IgG 
isotype control (Cell Signaling, cat. #2729) 1 μg/mg protein, IgM isotype control (eBioscience, cat. #14475282) 
1 μg/mg protein). Dynabeads Protein G (Invitrogen, sat. #10004D) were washed twice for 10 min at 4 °C in 1 ml 
lysis buffer while rotating and immune complexes were incubated with 1.5 mg beads for 45 min at 4 °C with gentle 
rotation. Dynabeads with bound protein were washed 5 × 5 min in 500 μL lysis buffer, boiled for 5 min at 95 °C 
with 80 μL X2 sample buffer, whirly mixed thoroughly, and incubated on ice for 30 min. Proteins were separated 
using SDS-PAGE and analysed by Western blotting as above. The data shown are representative of results from 4 
such experiments while 3 additional experiments showed inconsistent results, presumably reflecting a dynamic 
interaction sensitive to, e.g. confluence and cell passage number.
siRNA transfection. Two siRNA’s directed against RACK1 (NM_006098) and corresponding mock control 
oligo were purchased from OriGene (OriGene Technologies, Rockville, MD, #SR307048 and #SR30004). Cells 
were 50%-60% confluent upon transfection: medium was replaced with fresh growth medium without penicil-
lin/streptomycin, and cells were transfected with 20 nM siRNA using Lipofectamine 2000 (Invitrogen, #11668-
019) mixed in growth medium without serum and penicillin/streptomycin. 24 h after transfection, medium was 
replaced with full growth medium and 72 h after transfection, cells were processed for cell surface biotinylation 
(as described above but without polarization) followed by Western blotting.
FLAG-constructs and FLAG co-immunoprecipitation. Four different versions of the rat NBCn1 
(rNBCn1-D, NM_058211.2) 137 amino acid long C-terminus were amplified by PCR: full length C-terminus 
consisting of NBCn1 C-terminal amino acids 1118–1254 (137) and truncated versions of the C-terminus con-
sisting of NBCn1 C-terminal amino acids 1118–1239 (122), 1118–1158 (41) and 1118–1140 (22). Primers 
are given below. PCR-products were analyzed by gel electrophoresis and single band products were excised 
and subjected to DNA gel purification. Products were inserted into the pFLAG-CMV-2 expression plas-
mid using the In-Fusion HD Cloning Kit (Takara Bio USA) to construct N-terminally FLAG-tagged prod-
ucts. pFLAG-CMV-2 was linearized using EcoRI and KpnI. The resulting four plasmids were verified by 
restriction cutting and sequencing. Plasmids were transiently transfected into HEK293 cells at 60–80% 
confluence using Lipofectamine 3000 (Invitrogen). Medium was replaced with fresh growth medium after 
6 h incubation with transfection mixture. Twenty-four h after transfection cells were lysed and subjected 
to co-IP and Western blotting as described in the section “Native co-immunoprecipitation of NBCn1 and 
RACK1”. FLAG was precipitated using anti-FLAG M2 antibody (Sigma-Aldrich, #F1804) at 1 µg per mg pro-
tein in the IP sample. FW (all constructs) 5′-GCGGCCGCGGAATTCcccatgatggttcttgcattagtc-3′, Rev (137) 
5′-TCTAGAGTCGACTGGcaatgaagtttcagcatccatg-3′, Rev (122) 5′-TCTAGAGTCGACTGGtgtgagtgtg 
acaataaatttcgaa-3′, Rev (41) 5′-TCTAGAGTCGACTGGcttctccttcttcttcttgtcatc-3′ and Rev (22) 5′-TCTAGA 
GTCGACTGGtttcttactttctggcatgagg-3′.
NBCn1 internalization assay. MDCK-II cells cultured on Transwell filters for 4 days were labeled with 
0.2 mg/ml impermeable EZ-Link Sulfo-NHS-SS-Biotin, only added to the basolateral side of the filters, for 30 min 
at 4 °C, followed by quenching as described under “Cell surface biotinylation assay”. Except for a total surface 
control and a 0 min control, which remained at 4 °C in cold CO2-independent medium (CIM, Gibco #18045-088), 
cells were transferred to 37 °C pre-heated growth medium to allow protein internalization for the indicated time 
points. Subsequently, cells were returned to 4 °C to halt internalization and were washed 3 × 20 min with gentle 
shaking in a cold stripping buffer (75 mM reduced L-glutathione, 75 mM NaCl, 75 mM NaOH, 1% BSA, 10 mM 
ethylenediaminetetraacetic acid (EDTA), final pH 8.6) to remove biotin from non-internalized proteins. Finally, 
cells were washed several times in cold PBS, and either fixed in 4% PFA for immunofluorescence analysis or lysed 
in RIPA buffer and processed for cell surface biotinylation followed by Western blotting as described above.
Data and statistical analyses. Data are shown as representative individual experiments or presented as 
mean with SEM error bars. Significance between two groups was tested using Student t test and one- or two-way 
ANOVA, with Bonferroni or Dunnett’s post-test for comparison of more than two groups.
Data availability. The datasets generated and analyzed during the study are available from the correspond-
ing authors on reasonable request.
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